FGF2 and breast cancer: Our findings suggest that the lung microenvironment favors the growth and colonization of stem-like ALDHhiCD44+ breast cancer cells over non-stem-like ALDHloCD44− cells and that blockade of FGF2 in the lung results in decreased growth and colonization of TNBC potentially by targeting stemness/plasticity.